Entresto 97 MG-103 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FA16J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,703
Award facts
- Contract value 100% obligated
- $18,703.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 22, 2025, for the supply of Entresto 97 mg–103 mg tablets (60-count units) with a ceiling value of $18,703.31 under firm fixed-price terms. This non-set-aside delivery order is due for completion by October 23, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under the company's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.999 billion contract running through December 2026 that serves as the primary pharmaceutical supply mechanism for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, has established itself as a critical vendor within the federal medical supply chain through its extensive portfolio of competitively awarded contracts with the Defense Logistics Agency. The company supplies a comprehensive range of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Entresto, a combination cardiac medication, represents the type of specialty pharmaceutical product that the company routinely delivers through its DLA prime vendor arrangement, which encompasses brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FA16J?
SPE2DB26FA16J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 22, 2025.
How much is contract SPE2DB26FA16J worth?
The government has obligated $18,703 on SPE2DB26FA16J.
Is contract SPE2DB26FA16J an order under another contract?
Yes. SPE2DB26FA16J is a delivery order under SPE2DB20D2014, an indefinite delivery contract.
Was contract SPE2DB26FA16J competed?
The extent of competition for SPE2DB26FA16J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award